Symbols

INMB

INmune Bio·NASDAQ

--(--)

INMB Profile

Inmune Bio Inc.

A clinical-stage immunology company that developing immuno therapeutics for the treatment of cancer

Industry

Pharmaceutical

Established Date

09/25/2015

Listing Date

02/04/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.inmunebio.com

Security Type

Common stock

Office address

225 NE Mizner Blvd Suite 640 Boca Raton FL 33432

Business

Introduction

INmune Bio Inc. was originally incorporated in Nevada on September 25, 2015. The company is a clinical-stage biotechnology company focused on treating diseases driven by chronic inflammation and immune dysfunction by reprogramming the innate immune system. Its main project, CORDStrom, is a mesenchymal stromal cell platform for the treatment of recessive dystrophic epidermolysis bullosa, along with other R&D pipelines for neuroinflammation and oncology.